Quantbot Technologies LP Sells 30,935 Shares of Vital Farms, Inc. $VITL

Quantbot Technologies LP decreased its holdings in shares of Vital Farms, Inc. (NASDAQ:VITL) by 26.1% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 87,722 shares of the company’s stock after selling 30,935 shares during the period. Quantbot Technologies LP’s holdings in Vital Farms were worth $3,610,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in VITL. Exchange Traded Concepts LLC bought a new stake in shares of Vital Farms during the third quarter worth about $28,000. Assetmark Inc. boosted its stake in Vital Farms by 18.9% during the 2nd quarter. Assetmark Inc. now owns 3,153 shares of the company’s stock valued at $121,000 after purchasing an additional 501 shares during the last quarter. Jones Financial Companies Lllp boosted its stake in Vital Farms by 53.6% during the 3rd quarter. Jones Financial Companies Lllp now owns 3,197 shares of the company’s stock valued at $135,000 after purchasing an additional 1,116 shares during the last quarter. US Bancorp DE increased its holdings in Vital Farms by 48.3% during the 3rd quarter. US Bancorp DE now owns 3,369 shares of the company’s stock worth $139,000 after purchasing an additional 1,098 shares in the last quarter. Finally, State of Wyoming purchased a new stake in shares of Vital Farms in the second quarter worth approximately $141,000. 98.59% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Q4 revenue growth and top‑line clarity — Revenue rose ~28.6% year‑over‑year and Q4 revenue came in essentially inline with expectations, showing continued demand and scale benefits. This supports the company’s growth story even though EPS missed. MarketBeat / Press Release
• Neutral Sentiment: Board leadership transition — Founder Matt O’Hayer stepped down as Executive Chair; CEO Russell Diez‑Canseco was named Executive Chair to maintain continuity. This reduces governance uncertainty short‑term but is unlikely to change fundamentals immediately. Business Wire
• Negative Sentiment: EPS miss and mixed guidance reaction — Q4 EPS of $0.35 missed the $0.38 consensus (revenues roughly inline). Several outlets highlight the profit shortfall and guidance interpretation that disappointed some investors, which directly pressured the stock. Zacks
• Negative Sentiment: Securities‑class investigation announced — The Rosen Law Firm has opened an investigation alleging Vital Farms may have provided materially misleading information to investors. Such filings often increase short‑term selling pressure and can raise legal risk and potential future costs. GlobeNewswire
• Negative Sentiment: Analyst revisions and target cuts — Multiple firms updated coverage: Benchmark downgraded to “hold,” Morgan Stanley trimmed its price target to $24 (from $45), and Telsey cut its target to $35 while keeping an outperform stance. These moves reduce near‑term upside expectations and can amplify selling. Benzinga

Analysts Set New Price Targets

VITL has been the topic of several analyst reports. BMO Capital Markets cut their target price on Vital Farms from $60.00 to $50.00 and set an “outperform” rating on the stock in a research report on Thursday, December 18th. DA Davidson set a $47.00 price objective on Vital Farms and gave the company a “buy” rating in a research note on Wednesday, December 17th. TD Cowen reiterated a “buy” rating on shares of Vital Farms in a research note on Tuesday, January 20th. Zacks Research downgraded shares of Vital Farms from a “strong-buy” rating to a “hold” rating in a report on Friday, November 14th. Finally, Mizuho reduced their price objective on shares of Vital Farms from $53.00 to $48.00 and set an “outperform” rating for the company in a research report on Wednesday, November 26th. Nine research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $46.64.

Vital Farms Price Performance

Vital Farms stock opened at $21.09 on Monday. The business’s 50 day simple moving average is $28.60 and its 200 day simple moving average is $35.98. Vital Farms, Inc. has a 12 month low of $19.80 and a 12 month high of $53.13. The company has a market cap of $944.83 million, a price-to-earnings ratio of 14.65 and a beta of 1.14. The company has a current ratio of 2.16, a quick ratio of 1.61 and a debt-to-equity ratio of 0.01.

Vital Farms (NASDAQ:VITL) last issued its earnings results on Thursday, February 26th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.03). Vital Farms had a net margin of 8.73% and a return on equity of 20.69%. The firm had revenue of $213.55 million during the quarter, compared to the consensus estimate of $212.83 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The business’s quarterly revenue was up 28.6% compared to the same quarter last year. Sell-side analysts forecast that Vital Farms, Inc. will post 1.11 EPS for the current year.

Insider Activity at Vital Farms

In other Vital Farms news, CEO Russell Diez-Canseco sold 16,734 shares of the firm’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $35.05, for a total value of $586,526.70. Following the completion of the transaction, the chief executive officer owned 649,684 shares in the company, valued at $22,771,424.20. This trade represents a 2.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Matthew Ohayer sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $27.91, for a total transaction of $558,200.00. Following the transaction, the insider directly owned 6,341,190 shares of the company’s stock, valued at approximately $176,982,612.90. This represents a 0.31% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 66,734 shares of company stock worth $2,092,227. Insiders own 21.30% of the company’s stock.

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.